intertumoral molecular heterogeneity of non-small cell lung cancer with met exon 14 skipping – d...
Published 2 years ago • 116 plays • Length 6:21Download video MP4
Download video MP3
Similar videos
-
3:40
metex14 sas (met exon 14 skipping alterations) in non-small cell lung cancer
-
2:51
impaired c-met receptor degradation mediated by met exon 14 mutations in non–small-cell lung cancer
-
6:30
heterogeneity in non-small cell lung cancer
-
6:13
vision: tepotinib in met exon 14 skipping nsclc
-
1:18
amivantamab for nsclc with met exon 14 skipping mutations
-
1:02
investigating met exon 14 mutations in patients with nsclc
-
3:01
update from chrysalis: amivantamab in patients with nsclc with met exon 14 skipping mutation
-
16:35
heterogeneity of nsclc and precipitating oncogenic driver mutations
-
1:06
gregory j. riely provides an overview of met exon 14 skipping mutations in lung cancer
-
1:11
detecting the met exon 14 skipping mutations in nsclc
-
0:58
vision trial produces positive data in nsclc with met exon 14 mutations
-
1:22
gregory j. riely on the identification and treatment of patients with met exon 14 skipping mutations
-
0:54
what is a met mutation in non-small cell lung cancer (nsclc)?
-
13:06
met exon 14 mutations in mnsclc
-
24:19
tumor heterogeneity in small cell lung cancer and response to therapy - julien sage
-
1:33
tracking non-small cell lung cancer evolution through therapy (rx) (tracerx)
-
17:40
heterogeneity in non-small cell lung cancer through scrna-seq analysis by pallavi jain
-
0:49
the importance of metex14 testing in nsclc
-
3:24
impact of met inhibitors in met exon 14-mutant nsclc